Lobu



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 19.2%
Herpes Zoster 7.5%
Pyelonephritis 7.5%
Osteoporosis 6.7%
Product Used For Unknown Indication 6.7%
Cystitis 5.8%
Influenza 5.0%
Phantom Pain 5.0%
Rectal Cancer Metastatic 5.0%
Back Pain 3.3%
Hypertension 3.3%
Pain In Extremity 3.3%
Prophylaxis 3.3%
Pyrexia 3.3%
Breast Cancer 2.5%
Cerebral Oedema Management 2.5%
Insomnia 2.5%
Joint Sprain 2.5%
Myalgia 2.5%
Type 2 Diabetes Mellitus 2.5%
Agranulocytosis 10.0%
Altered State Of Consciousness 10.0%
Stevens-johnson Syndrome 10.0%
Duodenal Perforation 6.7%
Haemoglobin Decreased 6.7%
Urethral Haemorrhage 6.7%
Vomiting 6.7%
White Blood Cell Count Increased 6.7%
Aphasia 3.3%
Decreased Appetite 3.3%
Disease Progression 3.3%
Erosive Duodenitis 3.3%
Gastric Haemorrhage 3.3%
Liver Disorder 3.3%
Oedema 3.3%
Partial Seizures 3.3%
Skin Ulcer 3.3%
Somnolence 3.3%
Weight Decreased 3.3%
Concomitant
Prophylaxis 18.8%
Rheumatoid Arthritis 15.9%
Chronic Hepatitis C 6.8%
Cancer Pain 6.3%
Hypertension 5.3%
Product Used For Unknown Indication 5.2%
Drug Use For Unknown Indication 4.8%
Hepatitis C 4.6%
Constipation 4.1%
Colorectal Cancer 3.5%
Gastritis 3.2%
Osteoporosis 3.2%
Pain 3.1%
Stomatitis 2.7%
Gastric Ulcer 2.4%
Depression 2.1%
Insomnia 2.1%
Pneumonia 2.1%
Herpes Zoster 2.0%
Analgesic Therapy 1.7%
White Blood Cell Count Decreased 16.0%
Cerebral Haemorrhage 7.4%
Interstitial Lung Disease 7.4%
Upper Respiratory Tract Inflammation 6.4%
Hepatic Function Abnormal 5.3%
Neutrophil Count Decreased 5.3%
Vasculitis Necrotising 5.3%
Decreased Appetite 4.3%
Diarrhoea 4.3%
Fall 4.3%
Pyrexia 4.3%
Restlessness 4.3%
Candida Pneumonia 3.2%
Diabetes Mellitus 3.2%
Disease Progression 3.2%
Dysarthria 3.2%
Herpes Zoster 3.2%
Liver Disorder 3.2%
Lower Gastrointestinal Haemorrhage 3.2%
Malaise 3.2%
Interacting
Acute Myocardial Infarction 42.9%
Drug Use For Unknown Indication 42.9%
Insomnia 7.1%
Postoperative Analgesia 7.1%
Drug Interaction Potentiation 100.0%